To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UGGT1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
322 supporting clones for gene UGGT1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_020120.3   .a 1 to 10773 5 to 10777 exact RefSeq, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 10777/10777
(100 %)
0 diff
(100 %id)
BP356698 mammary gland .a 1 to 579 5 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB226703 trachea .a 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
BP364560 lung .a 17 to 598 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP280394   .a 25 to 607 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP310516 brain .a 25 to 566 1 to 542       542/588
(92 %)
21 diff
(96.5 %id)
BP359091 mammary gland .a 25 to 607 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA863681 placenta .a 30 to 622 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
AF227905 Liver .a 137 to 5046 1 to 4910 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 4910/4910
(100 %)
4 diff
(100.0 %id)
BQ378470 uterus_tumor .a 231 to 542 311 to 1       311/332
(93 %)
3 diff
(99.1 %id)
BE062610 breast .a 250 to 851 7 to 602   tiling clone,   596/610
(97 %)
19 diff
(96.9 %id)
DW466146 Liver .a 553 to 889 17 to 353       337/353
(95 %)
14 diff
(96.1 %id)
AW856017 colon .a 939 to 1173 245 to 16       233/267
(87 %)
7 diff
(97.4 %id)
BM474226 eye, retinoblastoma .a 944 to 1672 1 to 731       731/1021
(71 %)
8 diff
(99.3 %id)
BX474491   .a 1171 to 1785 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
AW500898 lymph .a 1227 to 1583 8 to 364       357/364
(98 %)
13 diff
(96.5 %id)
TI_154155361   .a 1227 to 1700 80 to 553       474/475
(99 %)
13 diff
(97.3 %id)
CF137866 lymph .a 1260 to 1711 1 to 452       452/452
(100 %)
7 diff
(98.5 %id)
TI_154167520   .a 1267 to 1735 80 to 548       469/472
(99 %)
3 diff
(99.4 %id)
CN428777 embryonic stem cells, DMSO-treated H9 cellline .a 1321 to 1813 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BU428913 lymph .a 1326 to 1663 8 to 345       338/345
(97 %)
6 diff
(98.3 %id)
DA576111   .a 1392 to 1936 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BQ189316 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1430 to 1841 1 to 413       413/433
(95 %)
8 diff
(98.2 %id)
TI_151731594   .a 1430 to 1841 491 to 80       412/1070
(38 %)
1 diff
(100.0 %id)
CV570851 cornea, eye .a 1756 to 2360 1 to 605       605/605
(100 %)
0 diff
(100 %id)
CD629834   .a 1828 to 2607 770 to 1       772/770
(100 %)
15 diff
(98.1 %id)
DA012739 adrenal gland .a 1864 to 2436 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
CD629842   .a 1880 to 2607 717 to 1       717/717
(100 %)
14 diff
(98.1 %id)
CD629830   .a 1891 to 2604 707 to 2       706/711
(99 %)
12 diff
(98.4 %id)
CD629832   .a 1891 to 2593 694 to 1       694/702
(98 %)
12 diff
(98.3 %id)
CD629826   .a 1897 to 2602 704 to 5       700/704
(99 %)
10 diff
(98.6 %id)
CD629838   .a 1902 to 2609 707 to 1       707/707
(100 %)
5 diff
(99.3 %id)
CD629835   .a 1904 to 2609 705 to 1       705/706
(99 %)
4 diff
(99.5 %id)
CD629827   .a 1907 to 2609 704 to 1       704/704
(100 %)
5 diff
(99.3 %id)
AK074251   .a 1973 to 5041 1 to 3069   available from FLJ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 3069/3069
(100 %)
5 diff
(99.9 %id)
BP239210 Liver .a 1973 to 2568 1 to 596       596/596
(100 %)
8 diff
(98.7 %id)
DB144048 thymus .a 1981 to 2511 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
BP240296 Liver .a 1983 to 2532 1 to 550       550/550
(100 %)
2 diff
(99.7 %id)
CD629843   .a 2054 to 2626 1 to 573       573/574
(99 %)
7 diff
(98.8 %id)
CD629846   .a 2054 to 2592 1 to 540       487/540
(90 %)
19 diff
(96.5 %id)
CD629844   .a 2056 to 2613 559 to 5       555/561
(98 %)
5 diff
(99.2 %id)
CD629847   .a 2172 to 2492 323 to 1       323/323
(100 %)
4 diff
(98.8 %id)
CD629845   .a 2212 to 2422 1 to 212       212/212
(100 %)
3 diff
(98.6 %id)
AK023671 placenta .a 2301 to 5046 1 to 2746   tiling clone, available from FLJ,   2746/2746
(100 %)
3 diff
(99.9 %id)
AU139468 placenta .a 2301 to 2828 2 to 535   capped   534/534
(100 %)
6 diff
(98.9 %id)
DA453463 tongue, tumor tissue .a 2445 to 3014 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA547561   .a 2526 to 3068 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BF370277 prostate_normal .a 2643 to 3002 1 to 358       358/358
(100 %)
5 diff
(98.7 %id)
BQ331014 lung_tumor .a 2696 to 2868 216 to 44       173/218
(79 %)
0 diff
(100 %id)
DA049114   .a 2715 to 3133 2 to 420   capped   419/419
(100 %)
1 diff
(99.8 %id)
BF880772 lung_tumor .a 2734 to 3212 482 to 5     Submitted on the opposite strand 478/482
(99 %)
0 diff
(100 %id)
BX475218   .a 2949 to 3484 1 to 536       536/536
(100 %)
0 diff
(100 %id)
DA865254 Prostate .a 2972 to 3732 2 to 761   capped   760/760
(100 %)
5 diff
(99.4 %id)
DA449600 tongue, tumor tissue .a 3078 to 3635 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BG115298 duodenal adenocarcinoma, cell line, small intestine .a 3158 to 3906 1 to 757       753/920
(81 %)
44 diff
(95.3 %id)
DN917343   .a 3217 to 3874 31 to 688       658/688
(95 %)
8 diff
(98.9 %id)
DN917926   .a 3217 to 3873 1 to 654       654/655
(99 %)
7 diff
(99.0 %id)
DB044989 testis .a 3287 to 3849 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
AA085901 colon, tumor .a 3298 to 3521 1 to 233       233/247
(94 %)
12 diff
(95.2 %id)
DA510870 brain .a 3329 to 3911 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
BE144774 head_neck .a 3352 to 3835 488 to 1     Submitted on the opposite strand 403/488
(82 %)
11 diff
(97.8 %id)
CB134088 Liver .a 3378 to 3974 1 to 597       597/597
(100 %)
7 diff
(98.9 %id)
BX472794   .a 3482 to 4069 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
BM746212 stomach .a 3573 to 4052 1 to 481       481/481
(100 %)
2 diff
(99.6 %id)
BM764495 stomach .a 3573 to 4220 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
BM765708 stomach .a 3573 to 3888 1 to 316       316/318
(99 %)
7 diff
(97.8 %id)
BM766025 stomach .a 3573 to 3952 1 to 380       380/380
(100 %)
1 diff
(99.8 %id)
BM771748 stomach .a 3580 to 4338 1 to 760       760/760
(100 %)
4 diff
(99.5 %id)
BE254640 eye, retinoblastoma .a 3583 to 4241 1 to 656       656/658
(99 %)
5 diff
(99.3 %id)
DW414360 Liver .a 3681 to 3981 16 to 316       301/316
(95 %)
9 diff
(97.2 %id)
DA644041   .a 3711 to 4292 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
BY996140   .a 3851 to 4540 30 to 719       690/719
(95 %)
6 diff
(99.2 %id)
AW380030 head_neck .a 3881 to 4189 308 to 3       306/308
(99 %)
8 diff
(97.5 %id)
BP214368 corpus callosum .a 3946 to 4527 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BG200176   .a 3990 to 4246 1 to 257       257/257
(100 %)
10 diff
(96.2 %id)
DA658737   .a 4005 to 4579 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AA852449 Bone, Hip .a 4032 to 4311 17 to 296       280/296
(94 %)
5 diff
(98.4 %id)
DA447062 tongue, tumor tissue .a 4068 to 4643 2 to 578   capped   577/577
(100 %)
6 diff
(99.0 %id)
CN428776 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4075 to 4467 1 to 394       394/394
(100 %)
1 diff
(99.8 %id)
BQ945763 leiomyosarcoma, uterus .a 4079 to 4814 1 to 736       736/903
(81 %)
5 diff
(99.5 %id)
DA588648 lung .a 4116 to 4688 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA876432 Prostate .a 4121 to 4679 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
BF753622 colon .a 4170 to 4584 415 to 1     Submitted on the opposite strand 415/415
(100 %)
0 diff
(100 %id)
AA701659 liver and spleen .a 4189 to 5042 862 to 3       859/862
(99 %)
37 diff
(95.8 %id)
BQ775587 Bone, Human Chondrosarcoma Cell Line .a 4239 to 4911 687 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 669/669
(100 %)
12 diff
(98.3 %id)
CX758632 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 4249 to 4963 1 to 704     Submitted on the opposite strand 704/814
(86 %)
14 diff
(98.3 %id)
BU623794 cell lines, Enchondroma .a 4262 to 4911 666 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 648/648
(100 %)
2 diff
(99.7 %id)
AW378961 head_neck .a 4276 to 4695 682 to 267       416/686
(60 %)
5 diff
(99.3 %id)
AW753578 colon .a 4277 to 4823 564 to 22       545/565
(96 %)
7 diff
(98.8 %id)
BU187231 eye, retinoblastoma .a 4294 to 5221 1 to 924   tiling clone,   924/924
(100 %)
5 diff
(99.5 %id)
AI911268 pooled .a 4309 to 4912 608 to 5       604/617
(97 %)
3 diff
(99.6 %id)
DN917925   .a 4314 to 4909 597 to 2       596/597
(99 %)
3 diff
(99.5 %id)
DN917342   .a 4316 to 4909 595 to 2       594/596
(99 %)
3 diff
(99.5 %id)
AW503100 lymph .a 4318 to 4783 1 to 466       466/466
(100 %)
6 diff
(98.8 %id)
TI_154158878   .a 4325 to 4983 89 to 746       658/664
(99 %)
22 diff
(96.7 %id)
AI608991 normal gingiva (cell line from primarykeratinocytes) .a 4342 to 5046 705 to 1       705/705
(100 %)
6 diff
(99.2 %id)
AA602525 adrenal adenoma, adrenal gland .a 4385 to 5042 656 to 2       655/658
(99 %)
18 diff
(97.3 %id)
BE930748 placenta_normal .a 4386 to 4630 305 to 62       244/305
(80 %)
1 diff
(99.7 %id)
TI_154136801   .a 4407 to 5046 699 to 60   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 640/1192
(53 %)
15 diff
(98.8 %id)
DA460091 tongue, tumor tissue .a 4426 to 4999 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
T67258.
matches multiple genes
liver and spleen .a 4428 to 4714 1 to 291     also hits gene spykerby 291/375
(77 %)
9 diff
(97.6 %id)
AA974166 pooled germ cell tumors .a 4456 to 4912 461 to 5       457/461
(99 %)
0 diff
(100 %id)
BG389281 embryonal carcinoma, cell line, testis .a 4469 to 5238 1 to 770       770/770
(100 %)
9 diff
(98.9 %id)
AI990584 pooled germ cell tumors .a 4477 to 4912 440 to 5       436/440
(99 %)
0 diff
(100 %id)
AW589739 pooled germ cell tumors .a 4510 to 4912 415 to 5       409/418
(97 %)
11 diff
(97.4 %id)
AU158039 placenta .a 4534 to 5046 520 to 1       520/543
(95 %)
16 diff
(97.1 %id)
AW177743 head_neck .a 4542 to 4741 200 to 1       200/200
(100 %)
0 diff
(100 %id)
AW751159 colon .a 4542 to 4734 192 to 1       192/192
(100 %)
2 diff
(99.0 %id)
BE140568 head_neck .a 4542 to 4741 201 to 1     Submitted on the opposite strand 201/201
(100 %)
3 diff
(98.6 %id)
BE140788 head_neck .a 4542 to 4741 200 to 1     Submitted on the opposite strand 200/200
(100 %)
0 diff
(100 %id)
AK023240   .a 4544 to 7609 1 to 3066   tiling clone, available from FLJ,   3066/3066
(100 %)
1 diff
(100.0 %id)
DB329229 Prostate .a 4544 to 5046 504 to 1       504/504
(100 %)
7 diff
(98.7 %id)
AU132160   .a 4545 to 5320 2 to 777   capped   776/776
(100 %)
2 diff
(99.8 %id)
BE268385 Burkitt lymphoma, lymph .a 4584 to 5254 15 to 681       667/681
(97 %)
14 diff
(98.0 %id)
BE397617 Burkitt lymphoma, lymph .a 4584 to 5286 30 to 731       702/738
(95 %)
14 diff
(98.2 %id)
BU663496 blood .a 4613 to 5183 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
BG118836 adenocarcinoma, cell line, Liver .a 4616 to 5246 1 to 628       628/928
(67 %)
10 diff
(99.0 %id)
BE396320 Burkitt lymphoma, lymph .a 4617 to 5347 1 to 724       724/726
(99 %)
12 diff
(98.4 %id)
AI655505 pooled germ cell tumors .a 4623 to 4911 289 to 1       289/289
(100 %)
1 diff
(99.7 %id)
AI655525 pooled germ cell tumors .a 4623 to 4911 289 to 1       289/289
(100 %)
0 diff
(100 %id)
AI655867 pooled germ cell tumors .a 4623 to 4911 289 to 1       289/289
(100 %)
0 diff
(100 %id)
AI632643 pooled germ cell tumors .a 4623 to 4907 289 to 5       285/289
(98 %)
0 diff
(100 %id)
AA703444 liver and spleen .a 4632 to 4997 366 to 1       366/368
(99 %)
2 diff
(99.5 %id)
TI_149288008   .a 4644 to 5399 829 to 79   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 751/984
(76 %)
13 diff
(98.7 %id)
AL702291 human skeletal muscle .a 4646 to 5071 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
BP237830 Liver .a 4658 to 5274 1 to 617       617/617
(100 %)
2 diff
(99.7 %id)
AW578675 colon .a 4706 to 4831 145 to 20       126/145
(86 %)
0 diff
(100 %id)
DA374449 thalamus .a 4719 to 5261 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
BX472174   .a 4726 to 5145 1 to 420       420/420
(100 %)
3 diff
(99.3 %id)
BP237664 Liver .a 4734 to 5309 1 to 576       576/576
(100 %)
5 diff
(99.2 %id)
BG110081 Bone, osteosarcoma, cell line .a 4734 to 5492 1 to 759       759/949
(79 %)
27 diff
(97.2 %id)
AA528513 Kidney .a 4756 to 4911 7 to 162   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 156/162
(96 %)
6 diff
(96.3 %id)
BU681194 lung .a 4804 to 5399 611 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 596/596
(100 %)
1 diff
(99.9 %id)
CA423294 cell lines, Chondrosarcoma .a 4804 to 5396 611 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 593/593
(100 %)
1 diff
(99.9 %id)
BX506373   .a 4823 to 5363 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
BF112249 pooled .a 4883 to 5401 524 to 6       519/524
(99 %)
0 diff
(100 %id)
AU124732   .a 4889 to 5689 2 to 801   capped   800/801
(99 %)
5 diff
(99.4 %id)
BE881501 large cell carcinoma, undifferentiated, lung .a 4897 to 5362 1 to 464       464/793
(58 %)
15 diff
(98.2 %id)
BM828578 Ascites, stomach .a 4930 to 5346 44 to 461       418/461
(90 %)
6 diff
(98.7 %id)
BF970661 adrenal cortex carcinoma, cell line, adrenal gland .a 4953 to 5646 1 to 690       690/932
(74 %)
10 diff
(99.0 %id)
AA644352 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4965 to 5400 470 to 34       437/470
(92 %)
0 diff
(100 %id)
BF349017 denis_drash .a 5038 to 5539 17 to 517       501/517
(96 %)
6 diff
(98.9 %id)
R41144   .a 5061 to 5371 1 to 311       311/316
(98 %)
3 diff
(99.1 %id)
DA356390 subthalamic nucleus .a 5086 to 5643 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BQ646317 hepatocellular carcinoma, cell line, Liver .a 5095 to 5929 1 to 858       858/974
(88 %)
33 diff
(96.7 %id)
BE834164 ovary .a 5117 to 5613 524 to 29       496/524
(94 %)
0 diff
(100 %id)
AU131669   .a 5129 to 5998 2 to 877   capped   876/876
(100 %)
12 diff
(98.7 %id)
EC457247 Prostate .a 5206 to 5299 98 to 5       94/98
(95 %)
0 diff
(100 %id)
EC471191 Prostate .a 5206 to 5299 94 to 1       94/94
(100 %)
0 diff
(100 %id)
EC568927 Prostate .a 5206 to 5299 98 to 5       94/98
(95 %)
0 diff
(100 %id)
DA651716   .a 5247 to 5798 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AW135426   .a 5249 to 5412 183 to 20       164/183
(89 %)
0 diff
(100 %id)
AW299703 Kidney .a 5398 to 5612 215 to 1       215/215
(100 %)
1 diff
(99.6 %id)
W58738 heart .a 5500 to 6105 1 to 611       611/611
(100 %)
12 diff
(98.1 %id)
DB271540 uterus .a 5533 to 6064 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
AW068880 Bone, Hip .a 5535 to 5829 58 to 352       295/352
(83 %)
6 diff
(98.3 %id)
CB152902 brain .a 5708 to 6256 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BX090991 liver and spleen .a 5849 to 6443 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
R13967 whole brain .a 5900 to 6333 1 to 445       445/448
(99 %)
19 diff
(95.8 %id)
BM478436 eye, retinoblastoma .a 5925 to 6676 13 to 766       754/784
(96 %)
8 diff
(99.0 %id)
CA442670 lung, Lung Focal Fibrosis .a 5942 to 6510 585 to 16   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 570/571
(99 %)
7 diff
(98.8 %id)
BM753978 stomach .a 5952 to 6338 1 to 395       395/395
(100 %)
19 diff
(95.2 %id)
AI672492 Kidney .a 5963 to 6513 553 to 3       551/553
(99 %)
0 diff
(100 %id)
BX486237   .a 5998 to 6309 1 to 312       312/312
(100 %)
3 diff
(99.1 %id)
R98442 liver and spleen .a 5998 to 6496 508 to 1       508/510
(99 %)
25 diff
(95.1 %id)
DW462424 Liver .a 6005 to 6362 11 to 368       358/368
(97 %)
6 diff
(98.4 %id)
H98941 melanocyte .a 6036 to 6501 477 to 1       477/478
(99 %)
15 diff
(96.9 %id)
BU955812 adenocarcinoma, cell line, breast .a 6048 to 6868 1 to 831       831/960
(86 %)
23 diff
(97.7 %id)
BU957133 adenocarcinoma, cell line, breast .a 6048 to 6627 1 to 581       581/1014
(57 %)
14 diff
(98.7 %id)
AW195290 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 6102 to 6515 415 to 1       415/415
(100 %)
5 diff
(98.8 %id)
AA554920 colon, tumor .a 6111 to 6514 405 to 2       404/405
(99 %)
0 diff
(100 %id)
BE550513 pooled germ cell tumors .a 6116 to 6515 400 to 1       400/400
(100 %)
0 diff
(100 %id)
BF515636   .a 6142 to 6515 386 to 13   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 374/374
(100 %)
4 diff
(99.0 %id)
AI080983 liver and spleen .a 6185 to 6506 322 to 1       322/322
(100 %)
0 diff
(100 %id)
BE164734 head_neck .a 6207 to 6485 278 to 1     Submitted on the opposite strand 278/278
(100 %)
3 diff
(99.0 %id)
BM749935 stomach .a 6257 to 6866 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
BM557306 melanotic melanoma, skin .a 6279 to 7227 1 to 962       962/1019
(94 %)
52 diff
(94.9 %id)
CN272115 embryonic stem cells, DMSO-treated H9 cellline .a 6357 to 6809 1 to 453       453/453
(100 %)
1 diff
(99.8 %id)
DA311749 hippocampus .a 6392 to 6881 2 to 492   capped   491/491
(100 %)
2 diff
(99.6 %id)
BQ362067 ovary .a 6465 to 6671 1 to 209       209/214
(97 %)
6 diff
(97.2 %id)
AA317096 lung .a 6533 to 6780 1 to 249       249/249
(100 %)
1 diff
(99.6 %id)
BM040793 Kidney, Wilms' tumor, cell line .a 6633 to 7372 1 to 739   tiling clone,   739/845
(87 %)
5 diff
(99.5 %id)
BM927891 hepatocellular carcinoma, cell line, Liver .a 6696 to 7570 1 to 882       882/1032
(85 %)
37 diff
(96.5 %id)
CV812448 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 6731 to 7387 1 to 661       661/733
(90 %)
47 diff
(93.6 %id)
CX784913 human embryonic stem cells .a 6817 to 7578 1 to 761       761/761
(100 %)
1 diff
(99.9 %id)
BE063280 breast .a 6866 to 7246 1 to 381       381/399
(95 %)
6 diff
(98.5 %id)
BM463172 melanotic melanoma, skin .a 6892 to 7366 189 to 663       475/667
(71 %)
2 diff
(99.8 %id)
BF800677 colon_ins .a 6927 to 7308 1 to 383       383/383
(100 %)
9 diff
(97.7 %id)
BQ361995 ovary .a 6929 to 7167 243 to 6       238/250
(95 %)
0 diff
(100 %id)
AL119946 amygdala .a 6980 to 7611 649 to 18     Submitted on the opposite strand 632/649
(97 %)
0 diff
(100 %id)
R76228 placenta .a 6980 to 7431 1 to 461       461/461
(100 %)
16 diff
(96.6 %id)
AA279242 germinal center B cell .a 7017 to 7229 1 to 213       213/213
(100 %)
0 diff
(100 %id)
BF376875 testis_normal .a 7031 to 7309 283 to 5       279/285
(97 %)
0 diff
(100 %id)
BQ376163 testis_normal .a 7031 to 7256 232 to 4       229/234
(97 %)
0 diff
(100 %id)
BG484279 lung .a 7033 to 7380 1 to 348       348/1036
(33 %)
3 diff
(99.8 %id)
AU153746   .a 7047 to 7609 558 to 1       558/558
(100 %)
15 diff
(97.4 %id)
AU148530   .a 7051 to 7609 556 to 1       556/557
(99 %)
10 diff
(98.3 %id)
BF812295 colon_ins .a 7090 to 7349 1 to 262       262/262
(100 %)
15 diff
(94.3 %id)
AA926726 pooled .a 7140 to 7611 472 to 1   tiling clone,   472/472
(100 %)
0 diff
(100 %id)
BF842272 head_neck .a 7154 to 7373 1 to 222       222/228
(97 %)
8 diff
(96.5 %id)
BF844728 head_neck .a 7155 to 7618 1 to 461       461/467
(98 %)
29 diff
(93.8 %id)
AI431817 Kidney .a 7169 to 7611 448 to 6       443/448
(98 %)
0 diff
(100 %id)
TI_149290377   .a 7193 to 7925 850 to 128   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 723/770
(93 %)
16 diff
(98.0 %id)
AW135879   .a 7219 to 7609 408 to 18   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 391/391
(100 %)
1 diff
(99.8 %id)
AU153378   .a 7265 to 7609 343 to 1       343/343
(100 %)
3 diff
(99.2 %id)
AW974767   .a 7314 to 7609 297 to 1     Submitted on the opposite strand 297/457
(64 %)
2 diff
(99.6 %id)
BU957055 adenocarcinoma, cell line, breast .a 7336 to 8003 1 to 671       671/853
(78 %)
6 diff
(99.3 %id)
BU173752 hepatocellular carcinoma, cell line, Liver .a 7349 to 7971 1 to 625       625/1169
(53 %)
23 diff
(98.1 %id)
BQ653210 hepatocellular carcinoma, cell line, Liver .a 7349 to 8201 1 to 854   tiling clone,   854/903
(94 %)
14 diff
(98.5 %id)
AI990926 pooled germ cell tumors .a 7363 to 7606 262 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 244/244
(100 %)
4 diff
(98.4 %id)
BU727707 eye, eye anterior segment .a 7366 to 7713 1 to 348     Submitted on the opposite strand 348/348
(100 %)
3 diff
(99.2 %id)
AA809295 germinal center B cell .a 7372 to 7822 1 to 451     Submitted on the opposite strand 451/451
(100 %)
2 diff
(99.6 %id)
AA847178 germinal center B cell .a 7374 to 7790 1 to 417       417/417
(100 %)
0 diff
(100 %id)
AA652741 normal prostate, Prostate .a 7395 to 7609 233 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 215/215
(100 %)
1 diff
(99.6 %id)
T19613   .a 7404 to 7651 249 to 1       249/249
(100 %)
6 diff
(97.6 %id)
BU681750 lung .a 7460 to 7925 484 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 466/466
(100 %)
3 diff
(99.4 %id)
BQ321725 colon .a 7472 to 7922 1 to 448       448/448
(100 %)
17 diff
(96.3 %id)
AW008850 colon .a 7472 to 7929 461 to 4       458/461
(99 %)
0 diff
(100 %id)
AA279123 germinal center B cell .a 7512 to 7862 351 to 1       351/351
(100 %)
0 diff
(100 %id)
CV805344 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 7532 to 8275 1 to 744   tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 744/744
(100 %)
7 diff
(99.1 %id)
CA429653 Cell Line, Chondrosarcoma .a 7574 to 8293 719 to 1   tiling clone,   719/719
(100 %)
25 diff
(96.6 %id)
BF592808 pooled germ cell tumors .a 7577 to 7862 312 to 27   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 286/286
(100 %)
0 diff
(100 %id)
AA736821 germinal center B cell .a 7600 to 7862 274 to 12   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 263/264
(99 %)
0 diff
(100 %id)
BF380021 uterus_tumor .a 7624 to 7911 12 to 297       286/297
(96 %)
6 diff
(98.0 %id)
AW080136 esophagus, squamous cell carcinoma .a 7924 to 8290 367 to 1   tiling clone,   367/367
(100 %)
15 diff
(96.0 %id)
BG253657 adenocarcinoma, cell line, Prostate .a 8336 to 9022 27 to 718   tiling clone,   692/758
(91 %)
36 diff
(95.3 %id)
DA345711 substantia nigra .a 8370 to 8955 2 to 587   tiling clone, capped   586/586
(100 %)
20 diff
(96.6 %id)
BX487129   .a 8534 to 8902 1 to 368   tiling clone,   368/368
(100 %)
4 diff
(99.0 %id)
AA278413 germinal center B cell .a 8687 to 9128 451 to 12     Submitted on the opposite strand 440/453
(97 %)
0 diff
(100 %id)
DA070772 cerebellum .a 8705 to 9244 2 to 541   tiling clone, capped   540/540
(100 %)
0 diff
(100 %id)
BF987753 placenta_normal .a 8730 to 8842 113 to 1       113/113
(100 %)
0 diff
(100 %id)
AA356464   .a 8790 to 8896 1 to 107       107/107
(100 %)
0 diff
(100 %id)
DB123664 thymus .a 8829 to 9456 2 to 630   tiling clone, capped   629/629
(100 %)
5 diff
(99.3 %id)
DA682685 ovary .a 9056 to 9617 2 to 565   tiling clone, capped   564/564
(100 %)
6 diff
(99.0 %id)
CD558264 White Matter .a 9214 to 9849 29 to 673   tiling clone,   645/944
(68 %)
24 diff
(97.5 %id)
AK025416 colon mucosa .a 9297 to 10773 562 to 2038   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 1477/2038
(72 %)
10 diff
(99.6 %id)
BG223245 moderate to poorly differentiated invasivecarcinoma, tongue .a 9367 to 9768 402 to 1       402/403
(99 %)
3 diff
(99.3 %id)
CN360950 embryonic stem cells, cell lines H1, H7, andH9 .a 9418 to 9928 13 to 523       511/523
(97 %)
6 diff
(98.9 %id)
CD106217 brain, Pituitary .a 9468 to 10346 1 to 886       886/891
(99 %)
16 diff
(98.3 %id)
AA280671 germinal center B cell .a 9557 to 9968 19 to 431     Submitted on the opposite strand 413/431
(95 %)
8 diff
(98.2 %id)
AA521176 germinal center B cell .a 9557 to 10083 19 to 545     Submitted on the opposite strand 527/545
(96 %)
6 diff
(98.9 %id)
CB215567 normal endometrium, late proliferativephase, cycle day 13, uterus .a 9603 to 10216 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BF175171 blood .a 9655 to 9901 1 to 247       247/247
(100 %)
2 diff
(99.2 %id)
BG998293 head_neck .a 9677 to 9990 319 to 6       314/319
(98 %)
0 diff
(100 %id)
AI243588 pooled .a 9699 to 10108 1 to 410     Submitted on the opposite strand 410/410
(100 %)
1 diff
(99.8 %id)
BF734627 amnion_normal .a 9733 to 10133 417 to 15     Submitted on the opposite strand 403/417
(96 %)
0 diff
(100 %id)
BE787942 large cell carcinoma, lung .a 9872 to 10526 1 to 666       666/720
(92 %)
15 diff
(98.0 %id)
BJ994760 hepatoblastoma .a 9902 to 10501 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
BC047727 Peripheral Nervous System, sympathetictrunk .a 9971 to 10752 1 to 782   available from MGC, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 782/782
(100 %)
0 diff
(100 %id)
BQ932226 sciatic nerve .a 9972 to 10752 1 to 783   available from MGC,   783/784
(99 %)
3 diff
(99.7 %id)
BQ349941 head_neck .a 9977 to 10351 385 to 12       374/397
(94 %)
0 diff
(100 %id)
BQ717269 sympathetic trunk .a 10014 to 10528 12 to 539       528/1106
(47 %)
39 diff
(96.5 %id)
BE174910 head_neck .a 10016 to 10351 46 to 382       337/385
(87 %)
6 diff
(98.5 %id)
BG104655 adrenal cortex carcinoma, cell line, adrenal gland .a 10071 to 10756 12 to 705       694/715
(97 %)
23 diff
(96.8 %id)
AI814744 adenocarcinoma, Pancreas .a 10094 to 10544 454 to 4       451/454
(99 %)
0 diff
(100 %id)
BF834969 head_neck .a 10126 to 10288 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
EC519446 Prostate .a 10133 to 10233 101 to 1       101/101
(100 %)
0 diff
(100 %id)
BG287465 bladder, transitional cell papilloma, cell line .a 10242 to 10736 1 to 500       500/846
(59 %)
9 diff
(99.0 %id)
DB297504 cerebellum .a 10250 to 10773 525 to 1       525/525
(100 %)
2 diff
(99.7 %id)
CN360949 embryonic stem cells, DMSO-treated H9 cellline .a 10253 to 10473 1 to 221       221/221
(100 %)
1 diff
(99.6 %id)
AA810550 germinal center B cell .a 10278 to 10629 362 to 11   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
AI696951 adenocarcinoma, Pancreas .a 10305 to 10750 446 to 1       446/446
(100 %)
0 diff
(100 %id)
GD152626   .a 10478 to 10756 1 to 279       279/281
(99 %)
11 diff
(96.1 %id)
AI571933 adenocarcinoma, Pancreas .a 10504 to 10756 282 to 30       253/282
(89 %)
0 diff
(100 %id)
AA652395 normal prostate, Prostate .a 10516 to 10657 144 to 3       142/144
(98 %)
0 diff
(100 %id)
AW002565 pooled germ cell tumors .a 10574 to 10773 213 to 14   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 200/200
(100 %)
0 diff
(100 %id)
AW444536   .a 10619 to 10756 149 to 12       138/159
(86 %)
0 diff
(100 %id)
AA908271 breast .a 10624 to 10752 149 to 21   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 129/132
(97 %)
0 diff
(100 %id)
CN266297 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 10634 to 10755 1 to 122       122/122
(100 %)
2 diff
(98.4 %id)
AI906855 breast .a 10635 to 10702 10 to 78       69/82
(84 %)
6 diff
(92.7 %id)
AI906857 breast .a 10635 to 10702 73 to 5       69/82
(84 %)
0 diff
(100 %id)
AI906858 breast .a 10635 to 10702 71 to 5       67/80
(83 %)
0 diff
(100 %id)
AI906866 breast .a 10635 to 10702 10 to 78       69/82
(84 %)
6 diff
(92.7 %id)
AK293066 uterus .b 1 to 5068 1 to 5068 K762E G830E N991S L1004P     5068/5068
(100 %)
8 diff
(99.9 %id)
NR_027671.2   .b 1 to 10930 1 to 10930 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) 10930/10930
(100 %)
0 diff
(100 %id)
DB276120 uterus .b 2 to 538 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
BC041098 Eye, retinoblastoma .b 4 to 6657 1 to 6654 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) 6654/6654
(100 %)
3 diff
(100.0 %id)
BM903853 eye, retinoblastoma .b 4 to 739 12 to 748       737/1030
(71 %)
17 diff
(98.4 %id)
CD629825   .b 9 to 611 31 to 635       605/666
(90 %)
11 diff
(98.4 %id)
CD629828   .b 9 to 681 28 to 701       674/701
(96 %)
8 diff
(98.9 %id)
CD629829   .b 9 to 693 28 to 715       688/715
(96 %)
15 diff
(98.0 %id)
CD629831   .b 9 to 632 32 to 655       624/655
(95 %)
9 diff
(98.7 %id)
CD629833   .b 9 to 681 33 to 702       670/702
(95 %)
11 diff
(98.5 %id)
CD629836   .b 9 to 636 31 to 665       633/665
(95 %)
9 diff
(98.7 %id)
CD629839   .b 9 to 697 30 to 711       682/713
(95 %)
16 diff
(97.8 %id)
CD629841   .b 9 to 716 28 to 743       716/744
(96 %)
17 diff
(97.8 %id)
BP221909   .b 20 to 600 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP364824 lung .b 111 to 697 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
AK309101 hippocampus .c 1 to 3113 1 to 3113 S330G tiling clone,   3113/3113
(100 %)
3 diff
(100.0 %id)
AA100700 colon, tumor .d 1 to 115 5 to 119   tiling clone,   115/120
(95 %)
3 diff
(97.5 %id)
AA088854 colon, tumor .d 1919 to 2469 554 to 1   tiling clone,   554/561
(98 %)
4 diff
(99.3 %id)
BE256101 eye, retinoblastoma .d 2401 to 2756 1 to 355   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 355/355
(100 %)
7 diff
(98.1 %id)
AK074376   .e 1 to 2040 1 to 2040 K188E tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2040/2044
(99 %)
6 diff
(99.8 %id)
BP243884 Liver .e 1 to 570 1 to 570       570/570
(100 %)
6 diff
(99.0 %id)
CF135562 lymph .f 1 to 703 8 to 710       703/710
(99 %)
8 diff
(98.9 %id)
TI_154163982   .f 1 to 842 77 to 915   tiling clone,   839/944
(88 %)
7 diff
(99.3 %id)
DN997461 breast cancer, Mammary gland (cancer tissue) .f 355 to 928 9 to 582   tiling clone,   574/582
(98 %)
6 diff
(99.0 %id)
AL601911   .g 1 to 694 1 to 694   tiling clone,   694/694
(100 %)
2 diff
(99.8 %id)
BM451280 eye, retinoblastoma .g 691 to 1260 1 to 567 Q123* tiling clone,   567/872
(65 %)
25 diff
(97.2 %id)
AW083330 colon, moderately differentiated adenocarcinoma .h 1 to 598 625 to 9 K11R K15N Y112C K113Q E114K ... tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 609/639
(95 %)
15 diff
(97.7 %id)
AA333308 Embryo, 8 weeks .i 1 to 388 1 to 391 L113A V115G L116F A117G Q118L ... tiling clone,   391/394
(99 %)
7 diff
(98.3 %id)
BE775113 uterus .j 1 to 431 1 to 431 exact tiling clone,   431/438
(98 %)
4 diff
(99.1 %id)
BE926758 breast .j 400 to 870 34 to 504   tiling clone,   471/504
(93 %)
8 diff
(98.5 %id)
CB995647 placenta, pre-eclamptic placenta .k-u 1 to 267 28 to 294       267/295
(90 %)
3 diff
(99.0 %id)
CB997742 placenta, pre-eclamptic placenta .k-u 1 to 712 28 to 744 exact tiling clone,   717/795
(90 %)
19 diff
(97.7 %id)
BF901906 marrow .l 1 to 431 1 to 431 G56A K75T S100X tiling clone,   431/448
(96 %)
3 diff
(99.4 %id)
BF902952 marrow .l 1 to 417 1 to 415   tiling clone,   415/419
(99 %)
9 diff
(97.9 %id)
BP239244 Liver .m 1 to 613 1 to 613 V11E tiling clone,   613/613
(100 %)
8 diff
(98.7 %id)
BP238350 Liver .m 87 to 699 1 to 613 exact tiling clone,   613/615
(99 %)
15 diff
(97.6 %id)
DA509093 brain .n 1 to 585 2 to 586 exact tiling clone, capped   585/585
(100 %)
0 diff
(100 %id)
BG957311 colon .o-u 1 to 219 10 to 228   tiling clone,   219/228
(96 %)
13 diff
(94.3 %id)
BG957113 colon .o-u 6 to 537 1 to 532   tiling clone,   532/532
(100 %)
1 diff
(99.9 %id)
BG957300 colon .o-u 6 to 565 1 to 560 C29W F52S L69V tiling clone,   560/560
(100 %)
4 diff
(99.3 %id)
BX492931   .p-u 1 to 562 1 to 562 exact tiling clone,   562/562
(100 %)
1 diff
(99.9 %id)
AI310093 2 pooled tumors (clear cell type), Kidney .q 1 to 349 353 to 5 exact tiling clone,   349/353
(98 %)
0 diff
(100 %id)
BJ996142 hepatoblastoma .q 4 to 521 1 to 518 exact tiling clone,   518/518
(100 %)
1 diff
(99.9 %id)
BM969706 lung, Primary Lung Epithelial Cells Gene UGGT1, variant not shown         Suspected internal deletion, this clone was ignored    
BX507825   Gene UGGT1, variant not shown         This clone was ignored    
AV659160 corresponding non cancerous liver tissue Gene UGGT1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB446620 testis Gene UGGT1, variant not shown         This clone was ignored    
DB105520 thymus Gene UGGT1, variant not shown       capped This clone was ignored    
DB342853 thymus Gene UGGT1, variant not shown         This clone was ignored    
DT218940 brain Gene UGGT1, variant not shown         This clone was ignored    
DA339786 hippocampus Gene UGGT1, variant not shown       capped      
AA232658 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene UGGT1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AA234388 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene UGGT1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AA279140 germinal center B cell Gene UGGT1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AA836255 germinal center B cell Gene UGGT1, variant not shown         Suspected internal deletion, this clone was ignored    
AI690870 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus Gene UGGT1, variant not shown         Suspected internal deletion, this clone was ignored    
BE550160 carcinoid, lung Gene UGGT1, variant not shown         This clone was ignored    
DA945337 Spleen Gene UGGT1, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA954939 Spleen Gene UGGT1, variant not shown       capped This clone was ignored    
DB333962 Spleen Gene UGGT1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m, .n, .o-u, .p-u, .q Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI